
Retatrutide (Reta) — 40 mg, 20 mg, 10 mg, 30 mg
Retatrutide (Reta) is the "triple agonist": it targets GLP-1, GIP and glucagon receptors at once, one step beyond semaglutide and tirzepatide research.
Key researched benefits
- Up to 24% average weight loss in a 48-week trial, among the largest results seen in this research class
- Liver fat dropped by up to 86% in trial participants, with most reaching normal levels
- Studied for less hunger, feeling full for longer and burning more stored fat for energy
- Better blood sugar and insulin response seen in metabolic studies
- Lower cholesterol, triglycerides and blood pressure reported in trial data
- Growing research into heart health, brain health (including dementia risk) and healthy ageing
Summarised from published laboratory and animal research. Not medical advice.
Sizes and pricing
- RT4040 mg$202.50In stock
- RT2020 mg$115In stock
- RT1010 mg$80In stock
- RT3030 mg$190Sold out
Prices in CAD and subject to change. $20 flat shipping across Canada, free over $300 after discounts.
Specifications
Advertised purity
99+%
Fill
95%+ of stated weight
Presentation
Lyophilized powder in a sealed vial
Storage
Reconstituted vials store at 2°C–8°C | New sealed vials 6+ months store in freezer
Documentation
Backed by the manufacturer, EnhancedHealth' own COAs, and client third-party testing
Independent testing
Janoshik or Freedom Diagnostics welcome
Certificate of Analysis
Every peptide we stock is backed by its manufacturer, EnhancedHealth ' own COAs, and client third-party testing. This product's certificate is not currently published online. See all published certificates.